For example, TPX2 is associated with poor survival in gastric cancer [35], targeting TPX2 can suppress tumor cell growth in prostate cancer, and TPX2 is a potential therapeutic target and a prognostic indicator in clear cell renal cell carcinoma [36]. This evidence concerns the gene TPX2 and neoplasm.